HomeAKRO • NASDAQ
add
Akero Therapeutics Inc
Previous close
$44.93
Day range
$43.33 - $45.44
Year range
$21.34 - $58.40
Market cap
3.48B USD
Avg Volume
1.04M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 80.87M | 23.02% |
Net income | -70.50M | -25.93% |
Net profit margin | — | — |
Earnings per share | -0.86 | -6.17% |
EBITDA | -80.87M | -23.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 742.32M | -2.35% |
Total assets | 1.11B | 28.22% |
Total liabilities | 83.33M | 24.42% |
Total equity | 1.03B | — |
Shares outstanding | 79.99M | — |
Price to book | 3.50 | — |
Return on assets | -17.85% | — |
Return on capital | -18.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -70.50M | -25.93% |
Cash from operations | -48.25M | 16.03% |
Cash from investing | 79.34M | 131.00% |
Cash from financing | 3.43M | 2,388.67% |
Net change in cash | 34.53M | 111.01% |
Free cash flow | -26.35M | 37.77% |
About
Founded
2017
Headquarters
Website
Employees
67
